MARKET

IRIX

IRIX

Iridex
NASDAQ
2.350
+0.030
+1.29%
Closed 16:00 12/02 EST
OPEN
2.140
PREV CLOSE
2.320
HIGH
2.441
LOW
2.140
VOLUME
4.91K
TURNOVER
9.66K
52 WEEK HIGH
6.68
52 WEEK LOW
1.960
MARKET CAP
37.58M
P/E (TTM)
-4.2259
1D
5D
1M
3M
1Y
5Y
IRIDEX Third Quarter 2022 Earnings: Beats Expectations
IRIDEX ( NASDAQ:IRIX ) Third Quarter 2022 Results Key Financial Results Revenue: US$14.6m (up 10% from 3Q 2021). Net...
Simply Wall St. · 11/13 12:48
Iridex stock rises after reporting Q3 results beat, reaffirming FY 2022 guidance
Seekingalpha · 11/11 19:01
Iridex (IRIX) Reports Q3 Loss, Tops Revenue Estimates
Iridex (IRIX) delivered earnings and revenue surprises of 26.67% and 5.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 11/10 23:35
IRIDEX GAAP EPS of -$0.11 beats by $0.03, revenue of $14.64M beats by $0.77M
Seekingalpha · 11/10 21:38
Iridex Q3 EPS $(0.11) Beats $(0.14) Estimate, Sales $14.60M Beat $13.87M Estimate
Benzinga · 11/10 21:21
Iridex Announces Record Third Quarter 2022 Financial Results
Company Announces FDA Clearance of new Iridex Pascal® Scanning Laser PlatformMOUNTAIN VIEW, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of g...
GlobeNewswire · 11/10 21:05
-- Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q3 Revenue $14.6M
-- Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q3 Revenue $14.6M
MT Newswires · 11/10 16:27
A number of insiders bought IRIDEX Corporation (NASDAQ:IRIX) stock last year, which is great news for shareholders
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
Simply Wall St. · 11/03 10:53
More
About IRIX
Iridex Corporation is an ophthalmic medical technology company, which is focused on the development and commercialization of products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. The Company’s laser consoles products consist of Glaucoma, which includes Cyclo G6 laser and delivery devices used for the treatment of glaucoma; Medical Retina product, which includes IQ 532 Laser and IQ 577 Laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases, and its PASCAL Synthesis Photocoagulator for the treatment of retinal diseases; Surgical Retina, which includes OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL and OcuLight GLx laser photocoagulation systems. Its laser probes products consist of Glaucoma, which include MicroPulse P3 Probe, G-Probe and G-Probe Illuminate, and Surgical Retina probes, which include EndoProbe family of products used in vitrectomy procedures.

Webull offers kinds of IRIDEX Corporation stock information, including NASDAQ:IRIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IRIX stock methods without spending real money on the virtual paper trading platform.